After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Get the (CGPI) Report Here
Trade with Jim Cramer 14 Days FREE
In my opinion, this list will outperform any other list of stocks anyone else could put together over the next 5 years.
Shares plunge 5.8% after a report showed paid clicks fell 0.3%.
CollaGenex agrees to a buyout, sending the stock soaring.
Emergent BioSolutions gains on a $448 million contract for its anthrax vaccine BioThrax.
Health stocks are flat Thursday, despite an abundance of news.
Biotech stocks were flat, but Viragen and MGI Pharma found success.
Health care stocks edge up, helped by successful drug studies and stock offerings.
CollaGenex jumps 11% after the FDA approves its pill to treat rosacea.
Iran, oil prices and the interest rate outlook are making market watchers jittery.
AVI BioPharma rises on news that the defense spending bill may direct $22 million to the company.
Of hundreds of suggestions, these are worth a mention -- though Markman doesn't necessarily agree.
Pure World doubles on buyout.
Ligand falls on delay of 10-K filing.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.